Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Liver Preservation Systems Market: By Preservation Technique, Static Cold Storage, Others), By Preservation Solution Solution, Human Biosystem Solution, Renograf, Viaspen, Lifor, Perfadex, Others), By End User, and Region Forecast 2019-2030
Liver Preservation Systems Market size was valued at US$ 174.2 million in 2023 expected to reach a value of US$ 1,949.5 million by 2030, growing at a CAGR of 41.2% from 2024-2030. Liver Preservation Systems is defined as the kind of technique that is used for recognizing numerous preservation solutions found in poultry. The method includes chickens, ducks, waterfowl, turkeys, and other birds. Several preservation solutions are seen in birds, such as Avian Mycoplasmosis, Avian Influenza, Infectious Bronchitis, Avian Salmonellosis, and others. A liver transplant, also called a hepatic transplant, can assist to save a person's life when the liver no longer functions. A doctor may counsel a liver transplant for an individual with end-stage liver illness. The rising prevalence of liver diseases and rising liver transplants as well as numerous products launched by the global market players. Liver preservation is the procedure of maintaining and protecting the donor liver from the liver gaining up to the establishment in the anticipated recipients. Oxygenation, Temperature, and other appropriate storage condition are to be kept to avoid liver injury throughout the preservation time, and liver works after the transplantation to recipients. The liver can be preserved in the preservation solution which is temperature-cooled to slow down the procedure of liver worsening from normal metabolic procedure. Liver procurement is typically achieved after the cardiac biomarkers death or brain death of the patients.
The global market provides a detailed overview of the and that can be segmented by preservation technique, by preservation solution, and by End user. By preservation technique, the market growth has been segmented into Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS), Others. The Static Cold Storage (SCS) segment is likely to be the significant growing segment in terms of preservation technique. Based on Preservation solution, the market is segmented into Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution, Human Biosystem (HBS) Solution, Renograf, Viaspen, Lifor, Perfadex, and Others. Among these, the Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution preservation solution segment is expected to have the significant growing market during the forecast period 2022-2028. Based on the End user, the Liver Preservation Systems market is segmented into Hospitals, Clinics, Others.
Study Period
2024-2030Base Year
2023CAGR
41.2%Largest Market
North AmericaFastest Growing Market
North America
The rising geriatric population is anticipated to propel the market growth over the forecast years. Moreover, the growth in cases of liver failure is burgeoning the market growth over the forecast years.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 174.2 million |
Market Size in 2030 |
US$ 1,949.5 million |
Market CAGR |
41.2% |
By Preservation Technique |
|
By Preservation solution |
|
By End User |
|
Download Free Sample Report
Liver preservation systems market size was valued at US$ 174.2 million in 2023 and is set to reach US$ 1,949.5 million growing at a CAGR of 41.2%.
The key players of liver preservation systems market are Franz Kohler Chemie GmbH (Germany), Organ Recovery Systems (U.S.), Waters Medical Systems LLC (U.S.), Essential, Pharmaceuticals LLC (U.S.), Xvivo Perfusion AB (Sweden), BioLife Solutions, Inc. (U.S.), Preservation Solutions, Inc. (U.S.), Transmedics, Inc. (U.S.), CryoLife, Inc. (U.S.)
North America is the fastest growing region.
1.Executive Summary |
2.Global Liver Preservation Systems Market Introduction |
2.1.Global Liver Preservation Systems Market - Taxonomy |
2.2.Global Liver Preservation Systems Market - Definitions |
2.2.1.Preservation Technique |
2.2.2.Preservation solution |
2.2.3.End User |
2.2.4.Region |
3.Global Liver Preservation Systems Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Liver Preservation Systems Market Analysis, 2018-2022 and Forecast 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Liver Preservation Systems Market By Preservation Technique, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Hypothermic Perfusion Preservation (HPP) |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Static Cold Storage (SCS) |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Others |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Liver Preservation Systems Market By Preservation solution, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Human Biosystem (HBS) Solution |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Renograf |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Viaspen |
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Lifor |
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Perfadex |
6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Others |
6.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
7.Global Liver Preservation Systems Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Clinics |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Liver Preservation Systems Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Liver Preservation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. Preservation Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Hypothermic Perfusion Preservation (HPP) |
9.1.2.Static Cold Storage (SCS) |
9.1.3.Others |
9.2. Preservation solution Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution |
9.2.2.Human Biosystem (HBS) Solution |
9.2.3.Renograf |
9.2.4.Viaspen |
9.2.5.Lifor |
9.2.6.Perfadex |
9.2.7.Others |
9.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Clinics |
9.3.3.Others |
9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Liver Preservation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Preservation Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Hypothermic Perfusion Preservation (HPP) |
10.1.2.Static Cold Storage (SCS) |
10.1.3.Others |
10.2. Preservation solution Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution |
10.2.2.Human Biosystem (HBS) Solution |
10.2.3.Renograf |
10.2.4.Viaspen |
10.2.5.Lifor |
10.2.6.Perfadex |
10.2.7.Others |
10.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Clinics |
10.3.3.Others |
10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11.Asia Pacific (APAC) Liver Preservation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Preservation Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Hypothermic Perfusion Preservation (HPP) |
11.1.2.Static Cold Storage (SCS) |
11.1.3.Others |
11.2. Preservation solution Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution |
11.2.2.Human Biosystem (HBS) Solution |
11.2.3.Renograf |
11.2.4.Viaspen |
11.2.5.Lifor |
11.2.6.Perfadex |
11.2.7.Others |
11.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Clinics |
11.3.3.Others |
11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Liver Preservation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Preservation Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Hypothermic Perfusion Preservation (HPP) |
12.1.2.Static Cold Storage (SCS) |
12.1.3.Others |
12.2. Preservation solution Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution |
12.2.2.Human Biosystem (HBS) Solution |
12.2.3.Renograf |
12.2.4.Viaspen |
12.2.5.Lifor |
12.2.6.Perfadex |
12.2.7.Others |
12.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Clinics |
12.3.3.Others |
12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Liver Preservation Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
13.1. Preservation Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Hypothermic Perfusion Preservation (HPP) |
13.1.2.Static Cold Storage (SCS) |
13.1.3.Others |
13.2. Preservation solution Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution |
13.2.2.Human Biosystem (HBS) Solution |
13.2.3.Renograf |
13.2.4.Viaspen |
13.2.5.Lifor |
13.2.6.Perfadex |
13.2.7.Others |
13.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Clinics |
13.3.3.Others |
13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Franz Kohler Chemie GmbH (Germany) |
14.2.2.Organ Recovery Systems (U.S.) |
14.2.3.Waters Medical Systems LLC (U.S.) |
14.2.4.Essential Pharmaceuticals LLC (U.S.) |
14.2.5.Xvivo Perfusion AB (Sweden) |
14.2.6.BioLife Solutions, Inc. (U.S.) |
14.2.7.Preservation Solutions, Inc. (U.S.) |
14.2.8.Transmedics, Inc. (U.S.) |
14.2.9.CryoLife, Inc. (U.S.) |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players